3.65 USD
-0.01 (-0.27%)
We assign a fundamental rating of 3 out of 10 to RYOJ. RYOJ was compared to 100 industry peers in the Health Care Providers & Services industry. RYOJ has an average financial health and profitability rating. RYOJ is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year RYOJ was profitable.
RYOJ had a positive operating cash flow in the past year.
1.2 Ratios
The Return On Assets of RYOJ (8.30%) is better than 92.00% of its industry peers.
The Return On Equity of RYOJ (52.85%) is better than 97.00% of its industry peers.
The Return On Invested Capital of RYOJ (10.05%) is better than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.3% | ||
| ROE | 52.85% | ||
| ROIC | 10.05% |
ROA(3y)3.47%
ROA(5y)N/A
ROE(3y)13.47%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
RYOJ has a Profit Margin of 11.51%. This is amongst the best in the industry. RYOJ outperforms 95.00% of its industry peers.
RYOJ has a Operating Margin of 16.07%. This is amongst the best in the industry. RYOJ outperforms 93.00% of its industry peers.
The Gross Margin of RYOJ (38.50%) is better than 68.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.07% | ||
| PM (TTM) | 11.51% | ||
| GM | 38.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so RYOJ is still creating some value.
The number of shares outstanding for RYOJ remains at a similar level compared to 1 year ago.
The debt/assets ratio for RYOJ has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.22 indicates that RYOJ is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.22, RYOJ is doing good in the industry, outperforming 68.00% of the companies in the same industry.
RYOJ has a debt to FCF ratio of 7.55. This is a slightly negative value and a sign of low solvency as RYOJ would need 7.55 years to pay back of all of its debts.
RYOJ has a Debt to FCF ratio (7.55) which is in line with its industry peers.
RYOJ has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of RYOJ (1.52) is worse than 69.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 7.55 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.71
WACC5.89%
2.3 Liquidity
RYOJ has a Current Ratio of 1.42. This is a normal value and indicates that RYOJ is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.42, RYOJ perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
RYOJ has a Quick Ratio of 1.40. This is a normal value and indicates that RYOJ is financially healthy and should not expect problems in meeting its short term obligations.
RYOJ has a Quick ratio of 1.40. This is comparable to the rest of the industry: RYOJ outperforms 59.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.4 |
3. Growth
3.1 Past
RYOJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.85%, which is quite impressive.
The Revenue has been growing slightly by 5.60% in the past year.
EPS 1Y (TTM)72.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.85%
Revenue 1Y (TTM)5.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.6%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 30.42 indicates a quite expensive valuation of RYOJ.
RYOJ's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of RYOJ to the average of the S&P500 Index (26.43), we can say RYOJ is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.42 | ||
| Fwd PE | N/A |
4.2 Price Multiples
RYOJ's Enterprise Value to EBITDA is on the same level as the industry average.
RYOJ's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 60.28 | ||
| EV/EBITDA | 18.78 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
RYOJ does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:RYOJ (12/17/2025, 4:04:47 PM)
3.65
-0.01 (-0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners51.51%
Ins Owner ChangeN/A
Market Cap41.06M
Revenue(TTM)11.58M
Net Income(TTM)1.33M
AnalystsN/A
Price TargetN/A
Short Float %1.42%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.42 | ||
| Fwd PE | N/A | ||
| P/S | 3.55 | ||
| P/FCF | 60.28 | ||
| P/OCF | 51.17 | ||
| P/B | 16.29 | ||
| P/tB | 47.47 | ||
| EV/EBITDA | 18.78 |
EPS(TTM)0.12
EY3.29%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY1.66%
OCF(TTM)0.07
OCFY1.95%
SpS1.03
BVpS0.22
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.78
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.3% | ||
| ROE | 52.85% | ||
| ROCE | 16.19% | ||
| ROIC | 10.05% | ||
| ROICexc | 13% | ||
| ROICexgc | 15.97% | ||
| OM | 16.07% | ||
| PM (TTM) | 11.51% | ||
| GM | 38.5% | ||
| FCFM | 5.88% |
ROA(3y)3.47%
ROA(5y)N/A
ROE(3y)13.47%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.52 | ||
| Debt/FCF | 7.55 | ||
| Debt/EBITDA | 1.64 | ||
| Cap/Depr | 25.83% | ||
| Cap/Sales | 1.05% | ||
| Interest Coverage | 24.07 | ||
| Cash Conversion | 34.43% | ||
| Profit Quality | 51.13% | ||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.4 | ||
| Altman-Z | 3.22 |
F-Score7
WACC5.89%
ROIC/WACC1.71
Cap/Depr(3y)211.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.85%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.6%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y147.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.27%
OCF growth 3YN/A
OCF growth 5YN/A
RYOJBABA CO LTD / RYOJ FAQ
What is the fundamental rating for RYOJ stock?
ChartMill assigns a fundamental rating of 3 / 10 to RYOJ.
What is the valuation status for RYOJ stock?
ChartMill assigns a valuation rating of 1 / 10 to RYOJBABA CO LTD (RYOJ). This can be considered as Overvalued.
How profitable is RYOJBABA CO LTD (RYOJ) stock?
RYOJBABA CO LTD (RYOJ) has a profitability rating of 5 / 10.
What is the financial health of RYOJBABA CO LTD (RYOJ) stock?
The financial health rating of RYOJBABA CO LTD (RYOJ) is 4 / 10.